|
Cross AS, Opal SM, Palardy JE, Shridhar S, Baliban SM, Scott AJ, Chahin AB, Ernst RK.
"A pilot study of an anti-endotoxin Ig-enriched bovine colostrum to prevent experimental sepsis." Innate Immunity, vol. 27, no. 3, 2021, pp. 266-274.
|
|
Hardy N, Zeba F, Ovalle A, Yanac A, Nzugang-Noutonsi C, Abadier M, Ovalle A, Chahin A.
"Association of prescription opioid use on mortality and hospital length of stay in the intensive care unit." PLoS ONE, vol. 16, no. 4, 2021, pp. e0250320.
|
|
Dhabaan G, Chahin A, Buhaish A, Shorman M.
"COVID-19 pandemic in Yemen: A questionnaire based survey, what do we know?." Journal of infection in developing countries, vol. 14, no. 12, 2020, pp. 1374-1379.
|
|
Lokhandwala, Sharukh, McCague, Ned, Chahin, Abdullah, Escobar, Braiam, Feng, Mengling, Ghassemi, Mohammad M., Stone, David J., Celi, Leo Anthony.
"One-year mortality after recovery from critical illness: A retrospective cohort study." PLOS ONE, vol. 13, no. 5, 2018, pp. e0197226.
|
|
Chahin AB, Opal JM, Opal SM.
"Whatever happened to the Shwartzman phenomenon?." Innate Immunity, vol. 24, no. 8, 2018, pp. 466-479.
|
|
Moskowitz A, Chen KP, Cooper AZ, Chahin A, Ghassemi MM, Celi LA.
"Management of Atrial Fibrillation with Rapid Ventricular Response in the Intensive Care Unit: A Secondary Analysis of Electronic Health Record Data." Shock, 2017.
|
|
Chahin, Abdullah, Opal, Steven M.
"Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations." Infectious Disease Clinics of North America, vol. 31, no. 1, 2017, pp. 111-121.
|
|
Clifford GD, Silva I, Moody B, Li Q, Kella D, Chahin A, Kooistra T, Perry D, Mark RG.
"False alarm reduction in critical care." Physiological measurement, vol. 37, no. 8, 2016, pp. E5-E23.
|
|
Marshall J, Chahin A, Rush B.
"Review of Clinical Databases." 2016.
|
|
Opal S, Ellis JL, Suri V, Freudenberg JM, Vlasuk GP, Li Y, Chahin AB, Palardy JE, Parejo N, Yamamoto M, Chahin A, Kessimian N.
"PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS." Shock, vol. 45, no. 4, 2015, pp. 411-8.
|
|
Lokhandwala, S, Escobar, B, Chahin, A, Mccague, N, Ghassemi, M, Feng, M, Celi, LA.
"RISK FACTORS FOR DEATH IN CHRONIC CRITICAL ILLNESS." Intensive Care Medicine Experimental, vol. 3, no. Suppl 1, 2015, pp. A449.
|
|
Chahin A, Opal SM, Zorzopulos J, Jobes DV, Migdady Y, Yamamoto M, Parejo N, Palardy JE, Horn DL.
"The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsis." Antimicrobial Agents and Chemotherapy, vol. 59, no. 2, 2015, pp. 1225-9.
|
|
Ramachandran G, Kaempfer R, Chung CS, Shirvan A, Chahin AB, Palardy JE, Parejo NA, Chen Y, Whitford M, Arad G, Hillman D, Shemesh R, Blackwelder W, Ayala A, Cross AS, Opal SM.
"CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and Gram-negative bacterial peritonitis." The Journal of Infectious Diseases, vol. 211, no. 6, 2014, pp. 809-20.
|
|
Sheth, Mallory Bounds, Chahin, Abdullah, Mark, Roger, Markuzon, Natasha.
"Protective effects of rheumatoid arthritis in septic ICU patients." 2014 IEEE International Conference on Big Data (Big Data), 2014.
|
|
Pop-Vicas A, Chahin A, Hagau D, Chapin K.
"Risk factors for prolonged H1N1 influenza among hospitalized patients." American journal of infection control, vol. 41, no. 12, 2013, pp. 1284-6.
|
|
Teleman, D, Chung, C-S, Ayala, A, Opal, S, Chahin, A, Shirvan, A.
"AB103, a CD28 antagonist peptide: a new therapeutic agent in a model of severe sepsis." Critical Care, vol. 15, no. Suppl 3, 2011, pp. P35.
|
